Employers should keep in mind that indication-based coverage decisions (such as covering GLP-1 drugs for diabetes treatment but not for treatment of obesity or other conditions, such as addiction) can potentially raise concerns under the Americans with Disabilities Act (ADA), the ACA, HIPAAs nondiscrimination requirements, or the Mental Health Parity and Addiction Equity Act, among other laws
Lab work: Some providers require periodic blood work to monitor metabolic markers
[DOI] [PubMed] [Google Scholar] 248
It needs to be provided with a support of essential amino acids, mainly lysine and methionine together with iron and vitamins C, B3 and B6, in order to be synthesised
Head to your local The Vitamin Shoppe or vitaminshoppe.com to get to it
2014;13(1):8-12. PMID: 26770075